Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    17551144 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Erlotinib;   Drug: Docetaxel

Study has passed its completion date and status has not been verified in more than two years.